File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1093/jleuko/qiad098
- Scopus: eid_2-s2.0-85181760923
- PMID: 37616269
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Organoids in COVID-19: can we break the glass ceiling?
Title | Organoids in COVID-19: can we break the glass ceiling? |
---|---|
Authors | |
Keywords | COVID-19 disease modeling organoids SARS-CoV-2 |
Issue Date | 1-Jan-2024 |
Publisher | Oxford University Press |
Citation | Journal of Leukocyte Biology, 2024, v. 115, n. 1, p. 85-99 How to Cite? |
Abstract | COVID-19 emerged in September 2020 as a disease caused by the virus SARS-CoV-2. The disease presented as pneumonia at first but later was shown to cause multisystem infections and long-term complications. Many efforts have been put into discovering the exact pathogenesis of the disease. In this review, we aim to discuss an emerging tool in disease modeling, organoids, in the investigation of COVID-19. This review will introduce some methods and breakthroughs achieved by organoids and the limitations of this system. |
Persistent Identifier | http://hdl.handle.net/10722/347530 |
ISSN | 2023 Impact Factor: 3.6 2023 SCImago Journal Rankings: 1.521 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chau, Chiu Wang | - |
dc.contributor.author | Sugimura, Ryohichi | - |
dc.date.accessioned | 2024-09-25T00:30:33Z | - |
dc.date.available | 2024-09-25T00:30:33Z | - |
dc.date.issued | 2024-01-01 | - |
dc.identifier.citation | Journal of Leukocyte Biology, 2024, v. 115, n. 1, p. 85-99 | - |
dc.identifier.issn | 0741-5400 | - |
dc.identifier.uri | http://hdl.handle.net/10722/347530 | - |
dc.description.abstract | COVID-19 emerged in September 2020 as a disease caused by the virus SARS-CoV-2. The disease presented as pneumonia at first but later was shown to cause multisystem infections and long-term complications. Many efforts have been put into discovering the exact pathogenesis of the disease. In this review, we aim to discuss an emerging tool in disease modeling, organoids, in the investigation of COVID-19. This review will introduce some methods and breakthroughs achieved by organoids and the limitations of this system. | - |
dc.language | eng | - |
dc.publisher | Oxford University Press | - |
dc.relation.ispartof | Journal of Leukocyte Biology | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | COVID-19 | - |
dc.subject | disease modeling | - |
dc.subject | organoids | - |
dc.subject | SARS-CoV-2 | - |
dc.title | Organoids in COVID-19: can we break the glass ceiling? | - |
dc.type | Article | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.1093/jleuko/qiad098 | - |
dc.identifier.pmid | 37616269 | - |
dc.identifier.scopus | eid_2-s2.0-85181760923 | - |
dc.identifier.volume | 115 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 85 | - |
dc.identifier.epage | 99 | - |
dc.identifier.eissn | 1938-3673 | - |
dc.identifier.issnl | 0741-5400 | - |